Most Recent Articles about BMY
Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod http://www.zacks.com/stock/news/432688/pharma-stock-roundup-pfe-to-buy-arry-rhhby-mrk-azn-drugs-get-regulatory-nod?cid=CS-ZC-FT-432688 Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
3 Big Biotechs Hold Growth Potential in Second Half of 2019 http://www.zacks.com/stock/news/432820/3-big-biotechs-hold-growth-potential-in-second-half-of-2019?cid=CS-ZC-FT-432820 Jun 21, 2019 - We highlight a few leading players from the biotech sector, having surpassed the same so far in 2019 and are likely to put up a good show during the second half of 2019 as well.
Zimmer taps BMY vet as CFO https://seekingalpha.com/news/3472529-zimmer-taps-bmy-vet-cfo?source=feed_news_all Jun 19, 2019 - Zimmer Biomet (NYSE:ZBH) announces that EVPĀ and Chief Financial Officer Daniel Florin will retire, effective July 1.Suketu Upadhyay has been appointed as the new CFO and comes on from his role as SVP,

Related Companies

Name Exchange Price Mkt Cap
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
AZN Astrazeneca PLC NYSE $37.56 $95.16B
SNY Sanofi NYSE $43.75 $109.14B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals